IPCA Laboratories Sees Strong Margin Expansion; Brokers See 15-28% Upside
Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as […]
Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as […]
A 50% revenue surge and 400% profit jump have made analysts sit up and take notice When a mid-cap jewellery
Lupin has delivered the goods this quarter. When a pharmaceutical company beats estimates across revenue, margins, and profit in a
There is a particular kind of market injustice reserved for companies that do everything right at the wrong time.
A blockbuster Q3 built on SUV dominance, a farm equipment supercycle and an EV business inching toward viability. Capacity expansion
India’s largest aluminium producer delivered solid domestic numbers. The problem is its American subsidiary is not firing on all cylinders,
IHCL’s Q3 numbers were fine. The real story is whether its aggressive asset-light expansion can keep the premium valuation alive
India’s largest jewellery company posted a good quarter riding the gold price surge, yet there is a genuine dilemma about
India’s second-largest commercial vehicle maker posted a quarter that beat expectations across the board, but with the stock’s upside hinges
India’s largest pizza chain posted its strongest margin quarter in recent memory, yet the stock remains caught between those who